Senator Sharafadeen Alli has sought the collaboration of the National Agency for Control of AIDS (NACA) towards enhancing the physical and mental well-being of his constituents in Oyo South Senatorial District and Oyo State.
Alli, as stated in a release by his Special Adviser (Media), Akeem Abas, made this known when he paid a courtesy visit on the Director-General of NACA, Dr. Temitope Ilori, in her office.
Alli, who was earlier inaugurated as a member of the ECOWAS Parliament, said the visit was aimed at fostering collaboration and partnership for the advancement and well-being of his constituents as well as the broader Oyo State community.
The lawmaker pledged his readiness to collaborate with NACA in various areas, including advocacy, campaigns and other beneficial projects aimed at enlightening and enhancing the welfare of constituents in Oyo South and the state at large.
In her response, Dr. Ilori commended Senator Alli for his proactive approach in seeking collaboration with NACA to address critical issues such as HIV/AIDS, which remains a significant challenge in society.
She described the initiative by the lawmaker as a commendable move towards improving the well-being of his constituents and joining the fight against the scourge of HIV/AIDS.
Dr. Ilori urged the lawmaker to incorporate the advocacy programmes and projects of NACA in his constituency development agenda to facilitate seamless collaboration and partnership between the agency and the senatorial district.
“This strategic alignment is poised to enhance the effectiveness of efforts aimed at combating HIV/AIDS and promoting public health in Oyo South Senatorial District.
“The collaborative efforts signify a proactive approach towards addressing pressing health challenges and advancing the socio-economic development of Oyo South Senatorial District.
“By leveraging synergies and pooling resources, both parties are poised to achieve meaningful impact and foster sustainable development within the district and Oyo State,” it was further stated in the release.